help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tonon, M. C.
Right arrow Articles by Vaudry, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tonon, M. C.
Right arrow Articles by Vaudry, H.

Endocrinology, Vol 112, 133-141, Copyright © 1983 by Endocrine Society


ARTICLES

Catecholaminergic control of alpha-melanocyte-stimulating hormone (alpha MSH) release by frog neurointermediate lobe in vitro: evidence for direct stimulation of alpha MSH release by thyrotropin-releasing hormone

MC Tonon, P Leroux, ME Stoeckel, S Jegou, G Pelletier and H Vaudry

The role of dopaminergic and adrenergic innervation of the intermediate lobe of amphibian pituitary in the release of alpha MSH has been studied in vitro. Neurointermediate lobes of frog (Rana ridibunda Pallas) have been perifused in amphibian culture medium (ACM) for 5-7 h. alpha MSH released in the effluent perifusate was measured by means of a sensitive and specific RIA. No significant morphological alteration of neurointermediate lobe cells was observed during the perifusion experiment, even at the electron microscopic level. The existence of dopaminergic receptors, responsible for an inhibition of frog melanotrophs, was shown using the dopaminergic agonists apomorphine (10(-6) M) and bromo-2-ergocryptine (10(-8) and 10(-7) M), which initiated a marked reduction of alpha MSH secretion. The effect of apomorphine was obliterated by the dopaminergic antagonist haloperidol. Haloperidol itself induced a dose-related stimulation, and the monoamine oxidase inhibitor nialamide (4 x 10(-3) M) inhibited alpha MSH secretion. In addition, haloperidol led to a complete reversal of the inhibitory effect of nialamide on alpha MSH secretion. These results demonstrate the existence, in the parenchyme of the intermediate lobe, of dopaminergic nerve fibers that are functionally active. The beta-adrenergic agonist isoproterenol was responsible for a dose-related stimulation of alpha MSH secretion; the stimulatory effect was reversed by the beta-adrenergic antagonist propranolol. TRH is a potent stimulator of alpha MSH secretion in amphibians. Since haloperidol and propranolol did not abolish the stimulation of alpha MSH release induced by TRH, it appeared that TRH action was not mediated via an inhibition of dopamine release or via a stimulation of adrenergic nerve fibers.


This article has been cited by other articles:


Home page
Ann. N. Y. Acad. Sci.Home page
L GALAS, I BIDAUD, M BULANT, B G JENKS, D T W M OUWENS, S JEGOU, A LADRAM, E W ROUBOS, P NICOLAS, M C TONON, et al.
In Situ Hybridization Localization of TRH Precursor and TRH Receptor mRNAs in the Brain and Pituitary of Xenopus laevis
Ann. N.Y. Acad. Sci., April 1, 2005; 1040(1): 95 - 105.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Tostivint, D. Vieau, N. Chartrel, I. Boutelet, L. Galas, A. Fournier, I. Lihrmann, and H. Vaudry
Expression and Processing of the [Pro2,Met13]Somatostatin-14 Precursor in the Intermediate Lobe of the Frog Pituitary
Endocrinology, September 1, 2002; 143(9): 3472 - 3481.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Galas, M.-C. Tonon, D. Beaujean, R. Fredriksson, D. Larhammar, I. Lihrmann, S. Jegou, A. Fournier, N. Chartrel, and H. Vaudry
Neuropeptide Y Inhibits Spontaneous {alpha}-Melanocyte-Stimulating Hormone ({alpha}-MSH) Release via a Y5 Receptor and Suppresses Thyrotropin-Releasing Hormone-Induced {alpha}-MSH Secretion via a Y1 Receptor in Frog Melanotrope Cells
Endocrinology, May 1, 2002; 143(5): 1686 - 1694.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
H. VAUDRY, N. CHARTREL, L. DESRUES, L. GALAS, S. KIKUYAMA, A. MOR, P. NICOLAS, and M. C. TONON
The Pituitary-Skin Connection in Amphibians: Reciprocal Regulation of Melanotrope Cells and Dermal Melanocytes
Ann. N.Y. Acad. Sci., October 20, 1999; 885(1): 41 - 56.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Galas, M. Lamacz, M. Garnier, E. W. Roubos, M.-C. Tonon, and H. Vaudry
Involvement of Protein Kinase C and Protein Tyrosine Kinase in Thyrotropin-Releasing Hormone-Induced Stimulation of {alpha}-Melanocyte-Stimulating Hormone Secretion in Frog Melanotrope Cells
Endocrinology, July 1, 1999; 140(7): 3264 - 3272.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
J. L. González de Aguilar, M. M. Malagón, R. M. Vázquez-Martínez, A. J. Martínez-Fuentes, M. C. Tonon, H. Vaudry, and F. Gracia-Navarro
Differential Effects of Dopamine on Two Frog Melanotrope Cell Subpopulations
Endocrinology, January 1, 1999; 140(1): 159 - 164.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
L. Desrues, M.-C. Tonon, J. Leprince, H. Vaudry, and J. M. Conlon
Isolation, Primary Structure, and Effects on {alpha}-Melanocyte-Stimulating Hormone Release of Frog Neurotensin
Endocrinology, October 1, 1998; 139(10): 4140 - 4146.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Garnier, M. Lamacz, L. Galas, S. Lenglet, M.-C. Tonon, and H. Vaudry
Pharmacological and Functional Characterization of Muscarinic Receptors in the Frog Pars Intermedia
Endocrinology, August 1, 1998; 139(8): 3525 - 3533.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. L. Gonzalez de Aguilar, M. M. Malagon, R. M. Vazquez-Martinez, I. Lihrmann, M.-C. Tonon, H. Vaudry, and F. Gracia-Navarro
Two Frog Melanotrope Cell Subpopulations Exhibiting Distinct Biochemical and Physiological Patterns in Basal Conditions and under Thyrotropin-Releasing Hormone Stimulation
Endocrinology, March 1, 1997; 138(3): 970 - 977.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1983 by The Endocrine Society